Nerve Graft Surgery for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Nerve Graft Surgery for Spinal Cord Injury?
Is nerve graft surgery for spinal cord injury generally safe for humans?
Surgical decompression, a procedure related to nerve graft surgery, is considered safe for patients with spinal cord injury, as no patients were made worse by the surgery. Durotomy, another related procedure, has shown positive effects on neurological function in most human studies, suggesting it may be safer than myelotomy.12678
How is the treatment Spinal Decompression Surgery unique for spinal cord injury?
Spinal Decompression Surgery, including techniques like durotomy and expansive duraplasty, is unique because it directly addresses the pressure and swelling in the spinal cord by expanding the protective covering (dura) around it, which is not achieved by bone decompression alone. This approach aims to prevent further injury and improve recovery by reducing pressure on the injured spinal cord.156910
Research Team
Francis H Farhadi, MD, PhD
Principal Investigator
University of Kentucky Neurosurgery
Eligibility Criteria
This trial is for adults aged 18-80 with acute traumatic spinal cord injury (SCI) at certain levels of the spine, who can consent and have surgery within 48 hours post-injury. Excluded are those with mild SCI, other serious conditions or mental impairments, substance abuse issues, pregnancy, involvement in another SCI study or if anterior-only spinal surgery is suitable.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo dorsal myelotomy and expansive duraplasty (DMED) with or without autologous nerve graft implantation (ANGI)
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Nerve Graft Implantation
- Spinal Decompression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kentucky
Lead Sponsor
H. Francis Farhadi
Lead Sponsor
Spinal Cord and Brain Injury Research Center (SCOBIRC)
Collaborator